Skip to main content

Table 1 Baseline characteristics of the two study groups

From: Loss of alveolar membrane diffusing capacity and pulmonary capillary blood volume in pulmonary arterial hypertension

Variable

Healthy

PAH

p-value

Ā 

Nā€‰=ā€‰41

Nā€‰=ā€‰28

Ā 

Age (years)

34 Ā±2

45 Ā±2

<0.01

Gender (M/F)

17/24

6/22

0.09

Smoking history (never/current/ex smoker)

40/0/1

24/1/3

0.1

Height (cm)

169 Ā±1

167 Ā±3

0.3

Weight (kg)

79 Ā±3

89 Ā±7

0.2

O2 Saturation (% of Hgb)

98 Ā±0.2

96 Ā±0.4

<0.01

FENO (ppb)

19 Ā±2

18 Ā±2

0.7

FVC (%)

98 Ā±2

91 Ā±3

0.2

FEV1 (%)

93 Ā±2

80 Ā±4

<0.01

FEV1/FVC

81 Ā±1

75 Ā±1

<0.01

TLC (%)

85 Ā±2

82 Ā±2

0.4

VA (L)

4.9 Ā±0.2

4.3 Ā±0.2

0.1

DLCO (ml/min/mmHg)

24 Ā±1

17 Ā±1

<0.01

DLNO (ml/min/mmHg)

94 Ā±4

66 Ā±5

<0.01

Dm (ml/min/mmHg)

48 Ā±2

33 Ā±2

<0.01

Vc (ml)

78 Ā±4

63 Ā±5

<0.01

Dm/Vc (1/min/mmHg)

0.6 Ā±0.02

0.6 Ā±0.04

0.8

Hgb (g/dl)

13.3 Ā±0.3

13.5 Ā±0.4

0.9

  1. F/M: female/male.
  2. FENO: fractional exhaled nitric oxide.
  3. FVC: forced vital capacity.
  4. FEV1: forced expiratory volume in one second.
  5. TLC: total lung capacity.
  6. VA: alveolar volume.
  7. DL: lung diffusion for carbon monoxide (DLCO) and for nitric oxide (DLNO).
  8. Dm: alveolar-capillary membrane diffusing capacity.
  9. Vc: lung capillary blood volume.
  10. Hgb: hemoglobin.
  11. PAH: pulmonary arterial hypertension.